We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
Cap. Flow
+$3.7B
Cap. Flow %
6.42%
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$379M
2
SHW icon
Sherwin-Williams
SHW
+$161M
3
NVDA icon
NVIDIA
NVDA
+$154M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$116M
5
BA icon
Boeing
BA
+$80M

Sector Composition

Rank Sector Weight
1 Technology 26.6%
2 Consumer Discretionary 15.59%
3 Communication Services 15.36%
4 Healthcare 13.38%
5 Financials 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GFS icon
451
GlobalFoundries
GFS
$27.5B
$331K ﹤0.01%
+4,586
New +$290K
INTC icon
452
Intel
INTC
$492B
$331K ﹤0.01%
10,139
-1,209
-11% -$34.3K
AMGN icon
453
Amgen
AMGN
$226B
$327K ﹤0.01%
1,351
+439
+48% +$108K
NTNX icon
454
Nutanix
NTNX
$17.4B
$321K ﹤0.01%
12,348
+10,141
+459% +$275K
ALB icon
455
Albemarle
ALB
$15.5B
$313K ﹤0.01%
1,416
+48
+4% +$11.8K
WCC
456
WESCO International
WCC
$17.9B
$303K ﹤0.01%
+1,962
New +$294K
ESTC icon
457
Elastic
ESTC
$7.93B
$293K ﹤0.01%
+5,065
New +$289K
VZ icon
458
Verizon
VZ
$195B
$282K ﹤0.01%
7,241
-11,846
-62% -$467K
CHWY icon
459
Chewy
CHWY
$9.25B
$277K ﹤0.01%
+7,422
New +$307K
UL icon
460
Unilever
UL
$135B
$274K ﹤0.01%
4,686
-48
-1% -$2.73K
VTEX icon
461
VTEX
VTEX
$687M
$271K ﹤0.01%
70,656
-78,403
-53% -$319K
ADM icon
462
Archer Daniels Midland
ADM
$38.8B
$265K ﹤0.01%
3,321
+454
+16% +$37.1K
LOW icon
463
Lowe's Companies
LOW
$123B
$265K ﹤0.01%
1,324
-27
-2% -$5.49K
DFS
464
DELISTED
Discover Financial Services
DFS
$254K ﹤0.01%
2,571
-6,664
-72% -$713K
CF icon
465
CF Industries
CF
$18.4B
$240K ﹤0.01%
3,306
-4,180
-56% -$342K
CAR icon
466
Avis
CAR
$4.9B
$239K ﹤0.01%
1,228
-493
-29% -$99K
KR icon
467
Kroger
KR
$34.6B
$237K ﹤0.01%
4,805
-2,308
-32% -$106K
GD icon
468
General Dynamics
GD
$107B
$232K ﹤0.01%
1,018
-146
-13% -$33.7K
CLVT icon
469
Clarivate
CLVT
$1.21B
$231K ﹤0.01%
24,556
-125
-0.5% -$1.29K
IBM icon
470
IBM
IBM
$223B
$216K ﹤0.01%
1,648
-547
-25% -$73.2K
INTU icon
471
Intuit
INTU
$91.5B
$207K ﹤0.01%
464
-142
-23% -$58.3K
FOX icon
472
Fox Class B
FOX
$23.6B
$203K ﹤0.01%
6,468
+1,113
+21% +$34.9K
CNC icon
473
Centene
CNC
$32.9B
$195K ﹤0.01%
3,082
-26
-0.8% -$1.85K
KWEB icon
474
KraneShares CSI China Internet ETF
KWEB
$5.76B
$195K ﹤0.01%
+6,242
New +$200K
PSX icon
475
Phillips 66
PSX
$86B
$193K ﹤0.01%
1,905
+1,505
+376% +$153K

Similar funds

Loomis, Sayles & Company's Q1 2023 Portfolio in Review

As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.

  • Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
  • Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
  • Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
  • Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
  • Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
  • Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
  • Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.

Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.